Interestingly, in contrast to the TRDV1-enriched c6, c10 was not enriched for the NKR NKp30 (NCR3) but rather for the NKR CD94/NKG2A, both at scRNA (Supplementary Fig. 14) and protein (Fig. 8F) level, indicating that the expression of this inhibitory NKR on adult blood anti-cancer Vγ9Vδ2 T cells109 is already programmed in the thymus (Fig. 8F; Supplementary Fig. S11C; Supplementary Fig. S12A, B; Supplementary Fig. 14). The gene discussed is KLRD1; the disease is cancer.